Genetic Technologies Provides Update on COVID-19 Disease Severity Test DevelopmentGlobeNewsWire • 09/15/20
Genetic Technologies Announces US Sales Have Commenced via Online Health PlatformGlobeNewsWire • 09/11/20
Genetic Technologies Regains Compliance with Nasdaq Stockholders Equity RequirementGlobeNewsWire • 09/01/20
Genetic Technologies Announces Closing of $5.1 Million Registered Direct OfferingGlobeNewsWire • 07/21/20
Genetic Technologies CEO to Participate in Investor Webinar and Q&A Session on June 24, 2020GlobeNewsWire • 06/23/20
Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score for COVID-19 CreatedGlobeNewsWire • 05/22/20
Genetic Technologies - Accelerated development of new COVID-19 Polygenic Risk Test for Risk of Developing Life-Threatening ComplicationsGlobeNewsWire • 05/20/20
Genetic Technologies Announces Closing of $1.8 Million Registered Direct OfferingGlobeNewsWire • 04/06/20
Genetic Technologies Limited Announces Market Update on Sales, Early Test Results and Launch of Consumer Initiated TestingGlobeNewsWire • 04/01/20
Genetic Technologies Limited Announces Receipt of Delisting Notification Letter from NasdaqGlobeNewsWire • 03/14/20
Genetype for Breast Cancer commissioned with sales to commence First Quarter 2020GlobeNewsWire • 12/10/19
Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming MilestonesGlobeNewsWire • 11/05/19
Collaboration Agreement Signed Between Genetic Technologies and Translational Genomics Research InstituteBenzinga • 09/23/19